ArticleBMC pharmacology & toxicology2026

A retrospective study of the efficacy and safety of rituximab biosimilar for the treatment of membranous nephropathy.

Yu-Zhen Zou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.